First line versus second line use of reslizumab in severe uncontrolled asthma

Autor: L A, Pérez de Llano, B G, Cosío, I, Lobato Astiárraga, G, Soto Campos, M A, Tejedor Alonso, N M, Malanda, A, Padilla Galo, I, Urrutia Landa, F J, Michel de la Rosa, I, García-Moguel

Publikováno v: Journal of Investigational Allergy and Clinical Immunology. 33

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3264d45858d7643ed3ba6c8248f2a0d7
https://doi.org/10.18176/jiaci.0839

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data.

Autor: Pérez de Llano LA; Pneumology Service, Hospital Lucus Augusti, Lugo, Spain., Cosío BG; Pneumology Service, Hospital Universitario Son Espases-IdISBa-Ciberes, Palma de Mallorca, Spain., Lobato Astiárraga I; Pneumology Service, Complejo Asistencial de Ávila, Ávila, Spain., Soto Campos G; Pneumology and Allergy Unit, University Hospital of Jerez, Jerez de la Frontera, Cádiz, Spain., Tejedor Alonso MÁ; Allergy Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Marina Malanda N; Pneumology Service, Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain., Padilla Galo A; Pneumology Service, Hospital Costa del Sol, Marbella, Málaga, Spain., Urrutia Landa I; Respiratory Department, Galdakao Hospital, Galdakao, Bizkaia, Spain., Michel de la Rosa FJ; Pneumology Service, Hospital Universitario Donostia, San Sebastian, Spain., García-Moguel I; Department of Allergy, Hospital Universitario 12 de Octubre, Madrid, Spain.

Publikováno v: Journal of asthma and allergy [J Asthma Allergy] 2022 Jan 14; Vol. 15, pp. 79-88. Date of Electronic Publication: 2022 Jan 14 (Print Publication: 2022).